

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.51858190 |
| 2 | wound healing, spreading of epidermal cells (GO:0035313) | 4.44272871 |
| 3 | response to peptidoglycan (GO:0032494) | 4.10989929 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.99300319 |
| 5 | wound healing, spreading of cells (GO:0044319) | 3.87832685 |
| 6 | endodermal cell differentiation (GO:0035987) | 3.82495929 |
| 7 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.78455093 |
| 8 | neutrophil activation (GO:0042119) | 3.75166511 |
| 9 | cell adhesion mediated by integrin (GO:0033627) | 3.73947568 |
| 10 | detection of other organism (GO:0098543) | 3.70598880 |
| 11 | leukocyte aggregation (GO:0070486) | 3.69616801 |
| 12 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.63613548 |
| 13 | granulocyte activation (GO:0036230) | 3.62607225 |
| 14 | hemidesmosome assembly (GO:0031581) | 3.60249559 |
| 15 | positive regulation of osteoblast proliferation (GO:0033690) | 3.58281934 |
| 16 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.54497553 |
| 17 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.53702489 |
| 18 | cellular response to interferon-alpha (GO:0035457) | 3.53253904 |
| 19 | desmosome organization (GO:0002934) | 3.52600648 |
| 20 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.50171162 |
| 21 | positive regulation by symbiont of host defense response (GO:0052509) | 3.43341611 |
| 22 | modulation by symbiont of host defense response (GO:0052031) | 3.43341611 |
| 23 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.43341611 |
| 24 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.43341611 |
| 25 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.43341611 |
| 26 | modulation by symbiont of host immune response (GO:0052553) | 3.43341611 |
| 27 | response to host immune response (GO:0052572) | 3.38915905 |
| 28 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.38915905 |
| 29 | mature B cell differentiation involved in immune response (GO:0002313) | 3.36053769 |
| 30 | regulation of monocyte chemotaxis (GO:0090025) | 3.35581301 |
| 31 | detection of bacterium (GO:0016045) | 3.34928522 |
| 32 | membrane raft organization (GO:0031579) | 3.28540272 |
| 33 | skin morphogenesis (GO:0043589) | 3.28387989 |
| 34 | respiratory burst (GO:0045730) | 3.27972869 |
| 35 | response to fungus (GO:0009620) | 3.26522721 |
| 36 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.25723929 |
| 37 | hypotonic response (GO:0006971) | 3.24738680 |
| 38 | regulation of tolerance induction (GO:0002643) | 3.24532067 |
| 39 | positive regulation of tolerance induction (GO:0002645) | 3.16800849 |
| 40 | regulation of natural killer cell differentiation (GO:0032823) | 3.15219888 |
| 41 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.14902572 |
| 42 | response to host (GO:0075136) | 3.14902572 |
| 43 | response to host defenses (GO:0052200) | 3.14902572 |
| 44 | regulation of metalloenzyme activity (GO:0048552) | 3.03795644 |
| 45 | positive regulation of interferon-alpha production (GO:0032727) | 2.99157270 |
| 46 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.99065972 |
| 47 | natural killer cell mediated immunity (GO:0002228) | 2.99065972 |
| 48 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.96793903 |
| 49 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.96236886 |
| 50 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.95245429 |
| 51 | collagen fibril organization (GO:0030199) | 2.94778923 |
| 52 | pinocytosis (GO:0006907) | 2.94722139 |
| 53 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.90034967 |
| 54 | negative regulation of mast cell activation (GO:0033004) | 2.87008113 |
| 55 | defense response to fungus (GO:0050832) | 2.86828355 |
| 56 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.86782192 |
| 57 | regulation of mononuclear cell migration (GO:0071675) | 2.86148556 |
| 58 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.83935070 |
| 59 | positive regulation of mast cell degranulation (GO:0043306) | 2.83935070 |
| 60 | negative regulation of interleukin-12 production (GO:0032695) | 2.83803273 |
| 61 | positive regulation of leukocyte degranulation (GO:0043302) | 2.83483395 |
| 62 | superoxide anion generation (GO:0042554) | 2.83291797 |
| 63 | detection of external biotic stimulus (GO:0098581) | 2.80578241 |
| 64 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.80046425 |
| 65 | macrophage activation involved in immune response (GO:0002281) | 2.79876341 |
| 66 | sequestering of metal ion (GO:0051238) | 2.79455350 |
| 67 | regulation of interferon-alpha production (GO:0032647) | 2.78565394 |
| 68 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.78536541 |
| 69 | immunoglobulin mediated immune response (GO:0016064) | 2.77848119 |
| 70 | regulation of T cell tolerance induction (GO:0002664) | 2.75900478 |
| 71 | chondrocyte proliferation (GO:0035988) | 2.74744902 |
| 72 | chronic inflammatory response (GO:0002544) | 2.71777677 |
| 73 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.68972623 |
| 74 | response to interferon-alpha (GO:0035455) | 2.68915622 |
| 75 | response to progesterone (GO:0032570) | 2.67274879 |
| 76 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.67156755 |
| 77 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.67045214 |
| 78 | cellular extravasation (GO:0045123) | 2.65414915 |
| 79 | fibril organization (GO:0097435) | 2.65005984 |
| 80 | positive regulation of mast cell activation (GO:0033005) | 2.64263317 |
| 81 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.64176813 |
| 82 | collagen metabolic process (GO:0032963) | 2.64174596 |
| 83 | regulation of hypersensitivity (GO:0002883) | 2.63721024 |
| 84 | response to muramyl dipeptide (GO:0032495) | 2.62175409 |
| 85 | metanephric mesenchyme development (GO:0072075) | 2.60341729 |
| 86 | reactive oxygen species biosynthetic process (GO:1903409) | 2.59318861 |
| 87 | B cell mediated immunity (GO:0019724) | 2.59001590 |
| 88 | collagen catabolic process (GO:0030574) | 2.58992961 |
| 89 | mature B cell differentiation (GO:0002335) | 2.57491551 |
| 90 | protein localization to endosome (GO:0036010) | 2.57421135 |
| 91 | regulation of podosome assembly (GO:0071801) | 2.54779808 |
| 92 | regulation of mast cell activation (GO:0033003) | 2.54691982 |
| 93 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.54481241 |
| 94 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.54349183 |
| 95 | apoptotic cell clearance (GO:0043277) | 2.53953757 |
| 96 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.53903429 |
| 97 | positive regulation of actin filament depolymerization (GO:0030836) | 2.52444153 |
| 98 | regulation of leukocyte degranulation (GO:0043300) | 2.52207852 |
| 99 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.50922107 |
| 100 | myeloid cell activation involved in immune response (GO:0002275) | 2.50339898 |
| 101 | regulation of chemokine biosynthetic process (GO:0045073) | 2.50336964 |
| 102 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.50084964 |
| 103 | regulation of macrophage cytokine production (GO:0010935) | 2.48933333 |
| 104 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.48827916 |
| 105 | kidney mesenchyme development (GO:0072074) | 2.48672219 |
| 106 | barbed-end actin filament capping (GO:0051016) | 2.48192201 |
| 107 | lipoxygenase pathway (GO:0019372) | 2.47042112 |
| 108 | detection of molecule of bacterial origin (GO:0032490) | 2.47042102 |
| 109 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.46704078 |
| 110 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.45572519 |
| 111 | neutrophil mediated immunity (GO:0002446) | 2.45329455 |
| 112 | extracellular matrix disassembly (GO:0022617) | 2.43652745 |
| 113 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.43118902 |
| 114 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.41229084 |
| 115 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.41058140 |
| 116 | positive regulation of interleukin-6 production (GO:0032755) | 2.40962163 |
| 117 | detection of biotic stimulus (GO:0009595) | 2.40674649 |
| 118 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.40175686 |
| 119 | mesodermal cell differentiation (GO:0048333) | 2.39418168 |
| 120 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.39178391 |
| 121 | actin nucleation (GO:0045010) | 2.39114643 |
| 122 | keratinocyte proliferation (GO:0043616) | 2.39016778 |
| 123 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.37556248 |
| 124 | regulation of mast cell degranulation (GO:0043304) | 2.36881547 |
| 125 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.36574530 |
| 126 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.36571538 |
| 127 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.36562328 |
| 128 | leukocyte mediated cytotoxicity (GO:0001909) | 2.35455415 |
| 129 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.35250557 |
| 130 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.34010632 |
| 131 | muscle cell migration (GO:0014812) | 2.33381065 |
| 132 | multicellular organismal catabolic process (GO:0044243) | 2.33314220 |
| 133 | regulation of interleukin-6 production (GO:0032675) | 2.32410028 |
| 134 | keratan sulfate catabolic process (GO:0042340) | 2.31960250 |
| 135 | positive regulation of extracellular matrix organization (GO:1903055) | 2.31547743 |
| 136 | * peptide cross-linking (GO:0018149) | 2.31375576 |
| 137 | positive regulation of interleukin-1 production (GO:0032732) | 2.30894955 |
| 138 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.30862467 |
| 139 | myoblast migration (GO:0051451) | 2.30796640 |
| 140 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.30224960 |
| 141 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.30080516 |
| 142 | phagocytosis, engulfment (GO:0006911) | 2.29606627 |
| 143 | substrate-dependent cell migration (GO:0006929) | 2.28468982 |
| 144 | extracellular fibril organization (GO:0043206) | 2.28424757 |
| 145 | establishment of endothelial barrier (GO:0061028) | 2.27815420 |
| 146 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.23878965 |
| 147 | positive regulation of lamellipodium assembly (GO:0010592) | 2.22320453 |
| 148 | negative regulation of cell killing (GO:0031342) | 2.21664359 |
| 149 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.21664359 |
| 150 | regulation of antigen processing and presentation (GO:0002577) | 2.21212788 |
| 151 | regulation of interleukin-17 production (GO:0032660) | 2.20943718 |
| 152 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.19593060 |
| 153 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.19309987 |
| 154 | cellular response to exogenous dsRNA (GO:0071360) | 2.18113904 |
| 155 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.17646553 |
| 156 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.17375445 |
| 157 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.16723475 |
| 158 | negative regulation of T cell mediated immunity (GO:0002710) | 2.15605469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.18883267 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.18654092 |
| 3 | * TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.10002379 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.90065082 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.67155540 |
| 6 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.50207464 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.27182846 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.93997290 |
| 9 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.92994597 |
| 10 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.80011871 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.79687831 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.79064075 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.63743419 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.58173990 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.57945836 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52604101 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.46501688 |
| 18 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.31819678 |
| 19 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.31819678 |
| 20 | * CJUN_26792858_Chip-Seq_BT549_Human | 2.14807156 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.11297833 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.10136158 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.03333791 |
| 24 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.03185404 |
| 25 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.99221703 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.98248105 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.98101603 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.95619221 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.92841763 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.85242198 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.84609842 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84097896 |
| 33 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.81723420 |
| 34 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.79561730 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79306012 |
| 36 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.75639386 |
| 37 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.74275310 |
| 38 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.74275310 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.72145765 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.63342275 |
| 41 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.62248464 |
| 42 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.61116030 |
| 43 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.59903364 |
| 44 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.59506420 |
| 45 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.52678095 |
| 46 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.51700927 |
| 47 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.51700619 |
| 48 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.48265049 |
| 49 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47194176 |
| 50 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.46472304 |
| 51 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.46187406 |
| 52 | MYB_26560356_Chip-Seq_TH1_Human | 1.45806427 |
| 53 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.44543947 |
| 54 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.43394006 |
| 55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39281464 |
| 56 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.39029187 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36934068 |
| 58 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34696639 |
| 59 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.33203604 |
| 60 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.29749630 |
| 61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.28756985 |
| 62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28487710 |
| 63 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27971231 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26775406 |
| 65 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.24819028 |
| 66 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24399442 |
| 67 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.22655799 |
| 68 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20788278 |
| 69 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20234869 |
| 70 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18484681 |
| 71 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.16894995 |
| 72 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.15439376 |
| 73 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15182413 |
| 74 | * MYB_26560356_Chip-Seq_TH2_Human | 1.14214523 |
| 75 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.12772136 |
| 76 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.11660032 |
| 77 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09190462 |
| 78 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.08964405 |
| 79 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.07856792 |
| 80 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.07706083 |
| 81 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06508254 |
| 82 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05959996 |
| 83 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05790760 |
| 84 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05685023 |
| 85 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03856114 |
| 86 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02424244 |
| 87 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.99649435 |
| 88 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.99263335 |
| 89 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97655693 |
| 90 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.97397365 |
| 91 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96420687 |
| 92 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96322579 |
| 93 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.95483899 |
| 94 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.94611973 |
| 95 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94452789 |
| 96 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92592759 |
| 97 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92568688 |
| 98 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90504222 |
| 99 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90349159 |
| 100 | MAF_26560356_Chip-Seq_TH1_Human | 0.90235429 |
| 101 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89957873 |
| 102 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.89850724 |
| 103 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89690974 |
| 104 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.89635571 |
| 105 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89329588 |
| 106 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89155788 |
| 107 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88749935 |
| 108 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87485831 |
| 109 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.87283785 |
| 110 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.86870888 |
| 111 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86808810 |
| 112 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.85986022 |
| 113 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84149013 |
| 114 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.82489615 |
| 115 | RXR_22108803_ChIP-Seq_LS180_Human | 0.82156091 |
| 116 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.82132701 |
| 117 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.81687512 |
| 118 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81326542 |
| 119 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.81069574 |
| 120 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80937689 |
| 121 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.79582960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.94140403 |
| 2 | MP0005275_abnormal_skin_tensile | 3.53836739 |
| 3 | MP0003436_decreased_susceptibility_to | 3.33638632 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 2.96493054 |
| 5 | MP0003566_abnormal_cell_adhesion | 2.80256162 |
| 6 | MP0009785_altered_susceptibility_to | 2.48853334 |
| 7 | MP0003303_peritoneal_inflammation | 2.42380542 |
| 8 | MP0003279_aneurysm | 2.36714851 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.36094952 |
| 10 | MP0001533_abnormal_skeleton_physiology | 2.30844572 |
| 11 | MP0005023_abnormal_wound_healing | 2.20005058 |
| 12 | MP0001958_emphysema | 2.18748076 |
| 13 | MP0002060_abnormal_skin_morphology | 2.18739608 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.09815562 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.08055878 |
| 16 | MP0005503_abnormal_tendon_morphology | 2.06820377 |
| 17 | * MP0002419_abnormal_innate_immunity | 2.04450721 |
| 18 | MP0003724_increased_susceptibility_to | 1.91669851 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 1.81427415 |
| 20 | MP0002796_impaired_skin_barrier | 1.77578373 |
| 21 | MP0003453_abnormal_keratinocyte_physiol | 1.73879442 |
| 22 | MP0005000_abnormal_immune_tolerance | 1.70750968 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 1.69905261 |
| 24 | MP0000858_altered_metastatic_potential | 1.69658697 |
| 25 | MP0004947_skin_inflammation | 1.68727996 |
| 26 | MP0000343_altered_response_to | 1.67621479 |
| 27 | MP0005025_abnormal_response_to | 1.66840088 |
| 28 | MP0005390_skeleton_phenotype | 1.66354192 |
| 29 | MP0002877_abnormal_melanocyte_morpholog | 1.64415423 |
| 30 | MP0004272_abnormal_basement_membrane | 1.64319550 |
| 31 | MP0003448_altered_tumor_morphology | 1.62491263 |
| 32 | MP0002933_joint_inflammation | 1.61521988 |
| 33 | MP0001853_heart_inflammation | 1.60701146 |
| 34 | MP0002254_reproductive_system_inflammat | 1.59835008 |
| 35 | MP0006054_spinal_hemorrhage | 1.59093198 |
| 36 | MP0003941_abnormal_skin_development | 1.54945962 |
| 37 | MP0001216_abnormal_epidermal_layer | 1.51218726 |
| 38 | MP0003091_abnormal_cell_migration | 1.50184471 |
| 39 | MP0001542_abnormal_bone_strength | 1.48068267 |
| 40 | MP0005671_abnormal_response_to | 1.44144513 |
| 41 | MP0002405_respiratory_system_inflammati | 1.42774186 |
| 42 | MP0005164_abnormal_response_to | 1.42197841 |
| 43 | MP0009384_cardiac_valve_regurgitation | 1.40639436 |
| 44 | MP0000685_abnormal_immune_system | 1.40369358 |
| 45 | MP0003763_abnormal_thymus_physiology | 1.35181358 |
| 46 | * MP0002452_abnormal_antigen_presenting | 1.34382541 |
| 47 | MP0005165_increased_susceptibility_to | 1.34107738 |
| 48 | MP0001851_eye_inflammation | 1.33552950 |
| 49 | MP0009278_abnormal_bone_marrow | 1.33326876 |
| 50 | MP0006082_CNS_inflammation | 1.31937158 |
| 51 | MP0002282_abnormal_trachea_morphology | 1.31289722 |
| 52 | MP0000383_abnormal_hair_follicle | 1.31085083 |
| 53 | MP0008004_abnormal_stomach_pH | 1.30072627 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.28878598 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.28154080 |
| 56 | MP0001790_abnormal_immune_system | 1.27621521 |
| 57 | MP0005387_immune_system_phenotype | 1.27621521 |
| 58 | MP0001243_abnormal_dermal_layer | 1.26056260 |
| 59 | MP0002396_abnormal_hematopoietic_system | 1.24613578 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.24583494 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.23559104 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.23472104 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.23472104 |
| 64 | MP0003950_abnormal_plasma_membrane | 1.21743476 |
| 65 | MP0009764_decreased_sensitivity_to | 1.19924003 |
| 66 | MP0003075_altered_response_to | 1.19097621 |
| 67 | MP0003300_gastrointestinal_ulcer | 1.17005345 |
| 68 | MP0003828_pulmonary_edema | 1.16900061 |
| 69 | MP0010678_abnormal_skin_adnexa | 1.16488878 |
| 70 | MP0005508_abnormal_skeleton_morphology | 1.15483435 |
| 71 | MP0004782_abnormal_surfactant_physiolog | 1.14511134 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.14114401 |
| 73 | MP0005464_abnormal_platelet_physiology | 1.13020032 |
| 74 | MP0005501_abnormal_skin_physiology | 1.12678985 |
| 75 | MP0002723_abnormal_immune_serum | 1.10068870 |
| 76 | * MP0001819_abnormal_immune_cell | 1.09946089 |
| 77 | * MP0001845_abnormal_inflammatory_respons | 1.09752088 |
| 78 | MP0002295_abnormal_pulmonary_circulatio | 1.08036864 |
| 79 | * MP0002420_abnormal_adaptive_immunity | 1.07554263 |
| 80 | MP0010771_integument_phenotype | 1.07485175 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 1.06180880 |
| 82 | MP0003795_abnormal_bone_structure | 1.05662905 |
| 83 | MP0004883_abnormal_blood_vessel | 1.05638225 |
| 84 | MP0008469_abnormal_protein_level | 1.04226104 |
| 85 | MP0000733_abnormal_muscle_development | 1.03922453 |
| 86 | MP0002098_abnormal_vibrissa_morphology | 1.03373766 |
| 87 | MP0005623_abnormal_meninges_morphology | 1.01217668 |
| 88 | MP0010368_abnormal_lymphatic_system | 0.98846448 |
| 89 | MP0000716_abnormal_immune_system | 0.97475051 |
| 90 | MP0001800_abnormal_humoral_immune | 0.97242088 |
| 91 | MP0005257_abnormal_intraocular_pressure | 0.96143970 |
| 92 | MP0002006_tumorigenesis | 0.95999063 |
| 93 | MP0005166_decreased_susceptibility_to | 0.95920929 |
| 94 | MP0002398_abnormal_bone_marrow | 0.95247009 |
| 95 | MP0001879_abnormal_lymphatic_vessel | 0.94935819 |
| 96 | MP0000249_abnormal_blood_vessel | 0.94217238 |
| 97 | MP0000377_abnormal_hair_follicle | 0.94002742 |
| 98 | MP0000465_gastrointestinal_hemorrhage | 0.93840040 |
| 99 | MP0003191_abnormal_cellular_cholesterol | 0.93815664 |
| 100 | MP0009763_increased_sensitivity_to | 0.92144587 |
| 101 | MP0003186_abnormal_redox_activity | 0.92109832 |
| 102 | MP0000762_abnormal_tongue_morphology | 0.91509893 |
| 103 | MP0001346_abnormal_lacrimal_gland | 0.89392700 |
| 104 | MP0002166_altered_tumor_susceptibility | 0.88746807 |
| 105 | MP0001191_abnormal_skin_condition | 0.86063591 |
| 106 | MP0000767_abnormal_smooth_muscle | 0.85994608 |
| 107 | MP0009931_abnormal_skin_appearance | 0.85133642 |
| 108 | MP0000681_abnormal_thyroid_gland | 0.84631919 |
| 109 | MP0009053_abnormal_anal_canal | 0.83182283 |
| 110 | MP0003045_fibrosis | 0.83175637 |
| 111 | MP0000467_abnormal_esophagus_morphology | 0.82838378 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.81356179 |
| 113 | MP0008260_abnormal_autophagy | 0.81060461 |
| 114 | MP0002896_abnormal_bone_mineralization | 0.80662088 |
| 115 | MP0000163_abnormal_cartilage_morphology | 0.80546993 |
| 116 | MP0005388_respiratory_system_phenotype | 0.80350830 |
| 117 | MP0002113_abnormal_skeleton_development | 0.79378970 |
| 118 | MP0000427_abnormal_hair_cycle | 0.79063607 |
| 119 | MP0004808_abnormal_hematopoietic_stem | 0.79045885 |
| 120 | MP0002429_abnormal_blood_cell | 0.78729918 |
| 121 | MP0000627_abnormal_mammary_gland | 0.77883188 |
| 122 | MP0002115_abnormal_skeleton_extremities | 0.77645950 |
| 123 | MP0002133_abnormal_respiratory_system | 0.75237586 |
| 124 | MP0002722_abnormal_immune_system | 0.74294816 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.75057125 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.46587831 |
| 3 | Premature rupture of membranes (HP:0001788) | 4.45075921 |
| 4 | Protrusio acetabuli (HP:0003179) | 3.99749160 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.74090584 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.69686511 |
| 7 | Cervical subluxation (HP:0003308) | 3.67807519 |
| 8 | Atrophic scars (HP:0001075) | 3.60471387 |
| 9 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.39430619 |
| 10 | Osteolytic defects of the hand bones (HP:0009699) | 3.39430619 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 3.30496665 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.30496665 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.30496665 |
| 14 | Vertebral compression fractures (HP:0002953) | 3.22358790 |
| 15 | Peritonitis (HP:0002586) | 3.10753420 |
| 16 | Abnormality of macrophages (HP:0004311) | 3.09459244 |
| 17 | Amyloidosis (HP:0011034) | 2.82696208 |
| 18 | Vacuolated lymphocytes (HP:0001922) | 2.79559590 |
| 19 | Right ventricular cardiomyopathy (HP:0011663) | 2.79433395 |
| 20 | Interstitial pulmonary disease (HP:0006530) | 2.74872778 |
| 21 | Autoimmune hemolytic anemia (HP:0001890) | 2.73528481 |
| 22 | Aortic dissection (HP:0002647) | 2.68036345 |
| 23 | Epiphyseal dysplasia (HP:0002656) | 2.65902359 |
| 24 | Thick nail (HP:0001805) | 2.65205887 |
| 25 | Dilatation of the ascending aorta (HP:0005111) | 2.61619211 |
| 26 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.60522742 |
| 27 | Pulmonary infiltrates (HP:0002113) | 2.57804833 |
| 28 | Aortic aneurysm (HP:0004942) | 2.55148065 |
| 29 | Gingivitis (HP:0000230) | 2.53157746 |
| 30 | Wormian bones (HP:0002645) | 2.52811643 |
| 31 | Neonatal short-limb short stature (HP:0008921) | 2.51014978 |
| 32 | Increased cerebral lipofuscin (HP:0011813) | 2.48533932 |
| 33 | Glucose intolerance (HP:0000833) | 2.48147608 |
| 34 | Distal lower limb muscle weakness (HP:0009053) | 2.46326393 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 2.44617981 |
| 36 | Pustule (HP:0200039) | 2.42829962 |
| 37 | Oral leukoplakia (HP:0002745) | 2.41845643 |
| 38 | Absent frontal sinuses (HP:0002688) | 2.41656443 |
| 39 | Stomatitis (HP:0010280) | 2.40459773 |
| 40 | Lip pit (HP:0100267) | 2.40100133 |
| 41 | Cupped ribs (HP:0000887) | 2.34059024 |
| 42 | Myositis (HP:0100614) | 2.33981116 |
| 43 | Short nail (HP:0001799) | 2.32991749 |
| 44 | Onycholysis (HP:0001806) | 2.32950521 |
| 45 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.32626691 |
| 46 | Milia (HP:0001056) | 2.32589094 |
| 47 | Beaking of vertebral bodies (HP:0004568) | 2.31699939 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.31336093 |
| 49 | Obstructive lung disease (HP:0006536) | 2.31336093 |
| 50 | Soft skin (HP:0000977) | 2.30448084 |
| 51 | Spinal cord lesions (HP:0100561) | 2.29433299 |
| 52 | Syringomyelia (HP:0003396) | 2.29433299 |
| 53 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.28253949 |
| 54 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.27841508 |
| 55 | Vascular tortuosity (HP:0004948) | 2.23673983 |
| 56 | Fragile skin (HP:0001030) | 2.23281188 |
| 57 | Nail dystrophy (HP:0008404) | 2.23006845 |
| 58 | Increased connective tissue (HP:0009025) | 2.22067100 |
| 59 | Plantar hyperkeratosis (HP:0007556) | 2.21798704 |
| 60 | Orchitis (HP:0100796) | 2.20835179 |
| 61 | Cellulitis (HP:0100658) | 2.20552747 |
| 62 | Xerostomia (HP:0000217) | 2.20225664 |
| 63 | Spondylolisthesis (HP:0003302) | 2.19974998 |
| 64 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.19760061 |
| 65 | Fragile nails (HP:0001808) | 2.18065507 |
| 66 | Spinal rigidity (HP:0003306) | 2.17600605 |
| 67 | Abnormality of T cell number (HP:0011839) | 2.16707556 |
| 68 | Abnormality of nail color (HP:0100643) | 2.16631813 |
| 69 | Cerebral aneurysm (HP:0004944) | 2.15322621 |
| 70 | Myocardial infarction (HP:0001658) | 2.14871887 |
| 71 | Increased IgE level (HP:0003212) | 2.13667528 |
| 72 | Ankle contracture (HP:0006466) | 2.13079805 |
| 73 | Dysostosis multiplex (HP:0000943) | 2.12053464 |
| 74 | Erythema (HP:0010783) | 2.10746004 |
| 75 | Fatigue (HP:0012378) | 2.09738404 |
| 76 | Hypergammaglobulinemia (HP:0010702) | 2.08838248 |
| 77 | Abnormality of the frontal sinuses (HP:0002687) | 2.08652359 |
| 78 | Glomerulopathy (HP:0100820) | 2.06838774 |
| 79 | T lymphocytopenia (HP:0005403) | 2.06082650 |
| 80 | Follicular hyperkeratosis (HP:0007502) | 2.03270690 |
| 81 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.03115438 |
| 82 | Alopecia of scalp (HP:0002293) | 2.02962941 |
| 83 | Natal tooth (HP:0000695) | 1.99144180 |
| 84 | Coxa vara (HP:0002812) | 1.98212212 |
| 85 | Keratoconjunctivitis sicca (HP:0001097) | 1.98080653 |
| 86 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.98028418 |
| 87 | Optic neuritis (HP:0100653) | 1.97779237 |
| 88 | Retrobulbar optic neuritis (HP:0100654) | 1.97779237 |
| 89 | Urticaria (HP:0001025) | 1.96181372 |
| 90 | Arterial tortuosity (HP:0005116) | 1.96026661 |
| 91 | Thrombocytosis (HP:0001894) | 1.94652303 |
| 92 | Palmar hyperkeratosis (HP:0010765) | 1.94540326 |
| 93 | Flat acetabular roof (HP:0003180) | 1.94240029 |
| 94 | Axonal loss (HP:0003447) | 1.94091499 |
| 95 | Blue sclerae (HP:0000592) | 1.93885082 |
| 96 | Gangrene (HP:0100758) | 1.93575113 |
| 97 | Recurrent skin infections (HP:0001581) | 1.93567799 |
| 98 | Metaphyseal dysplasia (HP:0100255) | 1.92918717 |
| 99 | Ulnar bowing (HP:0003031) | 1.92871755 |
| 100 | Abnormal blistering of the skin (HP:0008066) | 1.91846035 |
| 101 | Periodontitis (HP:0000704) | 1.90145923 |
| 102 | Autoimmune thrombocytopenia (HP:0001973) | 1.89051268 |
| 103 | Skin ulcer (HP:0200042) | 1.88666619 |
| 104 | Joint stiffness (HP:0001387) | 1.85749041 |
| 105 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.84629678 |
| 106 | Recurrent viral infections (HP:0004429) | 1.84453182 |
| 107 | Hematochezia (HP:0002573) | 1.84310856 |
| 108 | Disinhibition (HP:0000734) | 1.84083726 |
| 109 | Shallow orbits (HP:0000586) | 1.82591235 |
| 110 | Biconcave vertebral bodies (HP:0004586) | 1.82260345 |
| 111 | Abnormality of the nasal mucosa (HP:0000433) | 1.81298480 |
| 112 | Platyspondyly (HP:0000926) | 1.80670352 |
| 113 | Radial bowing (HP:0002986) | 1.80475221 |
| 114 | Loss of speech (HP:0002371) | 1.79443993 |
| 115 | Elbow flexion contracture (HP:0002987) | 1.79343657 |
| 116 | Granulocytopenia (HP:0001913) | 1.78900708 |
| 117 | Nuclear cataract (HP:0100018) | 1.78477238 |
| 118 | Nasal polyposis (HP:0100582) | 1.78183225 |
| 119 | Short middle phalanx of the 5th finger (HP:0004220) | 1.78013424 |
| 120 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.77752368 |
| 121 | Abnormality of the acetabulum (HP:0003170) | 1.77588322 |
| 122 | Vasculitis (HP:0002633) | 1.77470977 |
| 123 | Arterial thrombosis (HP:0004420) | 1.76175833 |
| 124 | Keratoconjunctivitis (HP:0001096) | 1.76124922 |
| 125 | Increased IgM level (HP:0003496) | 1.75996773 |
| 126 | Recurrent cutaneous fungal infections (HP:0011370) | 1.75662948 |
| 127 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.75662948 |
| 128 | Subacute progressive viral hepatitis (HP:0006572) | 1.75441048 |
| 129 | Osteomyelitis (HP:0002754) | 1.75261888 |
| 130 | Gastrointestinal infarctions (HP:0005244) | 1.74402809 |
| 131 | Hemoptysis (HP:0002105) | 1.72811923 |
| 132 | Abnormal foot bone ossification (HP:0010675) | 1.72721594 |
| 133 | Hepatosplenomegaly (HP:0001433) | 1.72131582 |
| 134 | Increased density of long bones (HP:0006392) | 1.71969096 |
| 135 | Palmoplantar hyperkeratosis (HP:0000972) | 1.71967153 |
| 136 | Abnormality of the odontoid process (HP:0003310) | 1.71929250 |
| 137 | Abnormality of T cell physiology (HP:0011840) | 1.71718952 |
| 138 | Recurrent fungal infections (HP:0002841) | 1.71706473 |
| 139 | Increased mean platelet volume (HP:0011877) | 1.70579877 |
| 140 | Systemic lupus erythematosus (HP:0002725) | 1.70183066 |
| 141 | Parakeratosis (HP:0001036) | 1.69389355 |
| 142 | Abnormality of the lumbar spine (HP:0100712) | 1.68231284 |
| 143 | Hypoplasia of the odontoid process (HP:0003311) | 1.67956062 |
| 144 | Abnormal vertebral ossification (HP:0100569) | 1.67128483 |
| 145 | Anhidrosis (HP:0000970) | 1.66674258 |
| 146 | Abnormal platelet volume (HP:0011876) | 1.66471567 |
| 147 | Abnormality of the pericardium (HP:0001697) | 1.65422719 |
| 148 | Ulnar deviation of the wrist (HP:0003049) | 1.65290329 |
| 149 | Spinal cord compression (HP:0002176) | 1.64626821 |
| 150 | Femoral bowing (HP:0002980) | 1.63405157 |
| 151 | Abnormality of dentin (HP:0010299) | 1.62932731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK1 | 3.47464427 |
| 2 | MAP3K3 | 2.82075526 |
| 3 | EPHA2 | 2.81067287 |
| 4 | MST4 | 2.74980753 |
| 5 | PBK | 2.50979483 |
| 6 | PIM2 | 2.44104956 |
| 7 | MST1R | 2.40174859 |
| 8 | MAP3K14 | 2.34056349 |
| 9 | TTN | 2.32820650 |
| 10 | ERN1 | 2.31743082 |
| 11 | LIMK1 | 2.22560957 |
| 12 | BLK | 1.99617131 |
| 13 | STK10 | 1.96754716 |
| 14 | GRK7 | 1.95610729 |
| 15 | TBK1 | 1.95420547 |
| 16 | LRRK2 | 1.93676694 |
| 17 | NEK9 | 1.93258927 |
| 18 | DDR2 | 1.93087961 |
| 19 | SIK3 | 1.93042824 |
| 20 | RIPK4 | 1.89374344 |
| 21 | SCYL2 | 1.88657506 |
| 22 | IRAK4 | 1.86128217 |
| 23 | RPS6KA4 | 1.84610557 |
| 24 | NME2 | 1.83817434 |
| 25 | EPHB2 | 1.68502092 |
| 26 | TRIB3 | 1.65023401 |
| 27 | TAOK3 | 1.60201257 |
| 28 | TGFBR2 | 1.56819343 |
| 29 | FLT3 | 1.54959441 |
| 30 | MAP2K3 | 1.53958466 |
| 31 | TYK2 | 1.46734142 |
| 32 | PIK3CG | 1.41066715 |
| 33 | EPHB1 | 1.39791135 |
| 34 | PTK2 | 1.35689483 |
| 35 | FRK | 1.34990534 |
| 36 | MOS | 1.34684558 |
| 37 | CSK | 1.31013015 |
| 38 | IKBKB | 1.28122425 |
| 39 | FER | 1.26621898 |
| 40 | TXK | 1.23183776 |
| 41 | MAPKAPK3 | 1.21747070 |
| 42 | TESK2 | 1.21480521 |
| 43 | EIF2AK3 | 1.21097026 |
| 44 | PRPF4B | 1.19999606 |
| 45 | BMX | 1.19837136 |
| 46 | TEC | 1.16448785 |
| 47 | IRAK3 | 1.13756680 |
| 48 | PTK6 | 1.12836290 |
| 49 | ERBB4 | 1.08048049 |
| 50 | MAP3K11 | 1.07239492 |
| 51 | PAK4 | 1.06626599 |
| 52 | MET | 1.05415722 |
| 53 | JAK3 | 1.05358675 |
| 54 | EPHA3 | 1.05305872 |
| 55 | PRKG2 | 1.01987803 |
| 56 | LATS1 | 1.01858663 |
| 57 | RIPK1 | 1.01118714 |
| 58 | IKBKE | 0.99489004 |
| 59 | ABL2 | 0.98311886 |
| 60 | CDK8 | 0.95355129 |
| 61 | FES | 0.95180982 |
| 62 | MAP3K6 | 0.91778844 |
| 63 | KIT | 0.90856449 |
| 64 | BTK | 0.89211778 |
| 65 | STK3 | 0.88285826 |
| 66 | JAK1 | 0.83692779 |
| 67 | GRK6 | 0.81009275 |
| 68 | MAP2K1 | 0.80871403 |
| 69 | MAPKAPK5 | 0.75088215 |
| 70 | MAP3K12 | 0.74808582 |
| 71 | BMPR1B | 0.74767689 |
| 72 | ZAP70 | 0.74619910 |
| 73 | MAPKAPK2 | 0.74255495 |
| 74 | MAP3K13 | 0.72719987 |
| 75 | TGFBR1 | 0.72666965 |
| 76 | CHUK | 0.72127163 |
| 77 | PDGFRA | 0.70239305 |
| 78 | FGR | 0.69765316 |
| 79 | MAPK15 | 0.69493661 |
| 80 | MAP3K2 | 0.68192104 |
| 81 | DMPK | 0.67520135 |
| 82 | * HCK | 0.67361171 |
| 83 | ILK | 0.66862526 |
| 84 | RPS6KB2 | 0.66344026 |
| 85 | KDR | 0.66061523 |
| 86 | PKN2 | 0.65948800 |
| 87 | LCK | 0.65501060 |
| 88 | PIK3CA | 0.65407545 |
| 89 | PAK2 | 0.64807801 |
| 90 | NUAK1 | 0.64320863 |
| 91 | SYK | 0.60183271 |
| 92 | MYLK | 0.60115329 |
| 93 | EIF2AK2 | 0.59157567 |
| 94 | TAOK1 | 0.58746695 |
| 95 | PIM1 | 0.58121580 |
| 96 | CDK6 | 0.56413675 |
| 97 | PRKCD | 0.56184768 |
| 98 | STK24 | 0.56089164 |
| 99 | BMPR2 | 0.55728647 |
| 100 | TAOK2 | 0.54969798 |
| 101 | FGFR3 | 0.54662856 |
| 102 | ROCK1 | 0.54059006 |
| 103 | PAK3 | 0.54020830 |
| 104 | MAPK7 | 0.53865937 |
| 105 | * TRPM7 | 0.53129984 |
| 106 | ITK | 0.53032420 |
| 107 | * ABL1 | 0.51765437 |
| 108 | CSF1R | 0.51260335 |
| 109 | JAK2 | 0.50836824 |
| 110 | PTK2B | 0.50796654 |
| 111 | MAP3K1 | 0.50483565 |
| 112 | PDGFRB | 0.50363073 |
| 113 | MATK | 0.50198714 |
| 114 | ZAK | 0.50096103 |
| 115 | * IGF1R | 0.46120544 |
| 116 | MAP3K8 | 0.45839876 |
| 117 | LATS2 | 0.45365637 |
| 118 | MAP4K1 | 0.45346686 |
| 119 | STK4 | 0.44065551 |
| 120 | FGFR1 | 0.42959713 |
| 121 | CLK1 | 0.41612795 |
| 122 | EIF2AK1 | 0.40868229 |
| 123 | LYN | 0.40796034 |
| 124 | GSK3A | 0.40210346 |
| 125 | NTRK1 | 0.39287426 |
| 126 | MAP3K5 | 0.38963275 |
| 127 | BCR | 0.38743477 |
| 128 | PAK1 | 0.37405585 |
| 129 | ROCK2 | 0.36969305 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.85888818 |
| 2 | Malaria_Homo sapiens_hsa05144 | 2.39138278 |
| 3 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.34858511 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.16626606 |
| 5 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.13509285 |
| 6 | Phagosome_Homo sapiens_hsa04145 | 2.07242959 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 2.05761157 |
| 8 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.98893269 |
| 9 | Shigellosis_Homo sapiens_hsa05131 | 1.94037581 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 1.92882108 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.91334471 |
| 12 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.90450742 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.84750677 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.79544627 |
| 15 | Salmonella infection_Homo sapiens_hsa05132 | 1.77862885 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77244591 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.75741223 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.75354159 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.71060821 |
| 20 | Amoebiasis_Homo sapiens_hsa05146 | 1.70968119 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.66805891 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.62366687 |
| 23 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.60212727 |
| 24 | Focal adhesion_Homo sapiens_hsa04510 | 1.56887878 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.54927562 |
| 26 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.54322094 |
| 27 | Adherens junction_Homo sapiens_hsa04520 | 1.53398643 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46439080 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.44493381 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.44385595 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.43128979 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.42912799 |
| 33 | Bladder cancer_Homo sapiens_hsa05219 | 1.39014966 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.37660542 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.35958089 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.34503731 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.32341758 |
| 38 | Proteasome_Homo sapiens_hsa03050 | 1.31221507 |
| 39 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.26251839 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.26162197 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.17040467 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.15876697 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.15834255 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.15769285 |
| 45 | Measles_Homo sapiens_hsa05162 | 1.12903024 |
| 46 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.12748200 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 1.12287582 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11657712 |
| 49 | Allograft rejection_Homo sapiens_hsa05330 | 1.07304917 |
| 50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05355541 |
| 51 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.04982965 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 1.04382319 |
| 53 | Asthma_Homo sapiens_hsa05310 | 1.01846386 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.99177117 |
| 55 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.98469094 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97720487 |
| 57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.93879090 |
| 58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93538741 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92709523 |
| 60 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.90504650 |
| 61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.90069995 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.88180288 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86267042 |
| 64 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.86061046 |
| 65 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.84555761 |
| 66 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.83127930 |
| 67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81919914 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.77251175 |
| 69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.76489596 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.75611294 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74497228 |
| 72 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74257116 |
| 73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72937673 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71457318 |
| 75 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.70028762 |
| 76 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.67962009 |
| 77 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67921070 |
| 78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66191680 |
| 79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65891995 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65524985 |
| 81 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.64972674 |
| 82 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.64337436 |
| 83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63514084 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61601884 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59287951 |
| 86 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.59236668 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58209755 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.58132727 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58093018 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.56947177 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56855130 |
| 92 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.56184853 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55286768 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54896188 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54682243 |
| 96 | Melanoma_Homo sapiens_hsa05218 | 0.54094975 |
| 97 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53245523 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52727449 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52027992 |
| 100 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50873355 |
| 101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50552894 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | 0.49708828 |
| 103 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.49191450 |
| 104 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.48567582 |
| 105 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47794972 |
| 106 | Tight junction_Homo sapiens_hsa04530 | 0.46913876 |
| 107 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45804276 |
| 108 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44202236 |
| 109 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41873048 |
| 110 | Prostate cancer_Homo sapiens_hsa05215 | 0.40715462 |
| 111 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38539637 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34558788 |
| 113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29495977 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27152924 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.27043719 |

